MUSC Names Goodwin as Chief Innovation Officer
July 2, 2018
CHARLESTON, SC – The Medical University of South Carolina (MUSC) has named Jesse S. Goodwin, Ph.D., chief innovation officer, effective July 2. Goodwin is charged with building a culture of innovation and creating an effective and efficient pipeline for innovation at MUSC.
“There are many great innovations emerging from MUSC and we need a visionary leader to help us fully develop our potential in this area and to build bridges between MUSC and industry,” said Lisa K. Saladin, Ph.D., MUSC executive vice president for academic affairs and provost. “Jesse Goodwin is a perfect fit for the role and I am excited that she has accepted this new position.”
Goodwin will have oversight of innovation across the enterprise, working closely with MUSC’s existing innovation-focused teams to build resources supporting and expanding the university’s entrepreneurial ecosystem, and to catalyze MUSC faculty, staff and students to generate new ideas, develop new skill sets, and embrace different perspectives that achieve impactful innovation in the laboratory, classroom, and clinic. In addition, Goodwin is committed to developing and fostering long-term public-private partnerships through sponsored research, corporate alliances, and other opportunities for collaboration.
“I am excited to be a partner in growing and building upon the innovation infrastructure already existing at MUSC in so many key areas, including research, clinical care delivery, medical device development, and digital health solutions,” she said. “Backed by the strong support of MUSC’s administration, I believe MUSC is positioned for great success.”
Goodwin has more than a decade of experience in identifying intellectual property strategies for broad range medical therapies for academia and industry. She has a demonstrated track record for driving improved outcome metrics and process improvements that lead to transparency, efficiency and accountability. Prior to accepting the role of chief innovation officer, Goodwin was vice president of development for the Zucker Institute for Applied Neurosciences, a technology accelerator working to develop and commercialize technologies generated by the department of Neurosciences at MUSC. Goodwin has been deeply engaged in innovation, more recently, leading the therapeutics translation core for SCTR, and serving as the Deputy Director for the MUSC Foundation for Research development, the university’s technology transfer office responsible for managing intellectual property. Prior to joining MUSC, Goodwin was the director of the medical device practice of a Boston-based intellectual property consulting firm.
Goodwin earned her bachelor of science degree in bioengineering from Syracuse University in New York and her doctorate in philosophy in biomedical engineering from Stony Brook University, also in New York. She served as a post-doctoral associate in the Harvard-MIT division of Health Sciences and Technology in Cambridge, MA, and enjoyed numerous research opportunities in labs at both Stony Brook and MIT.
About MUSC Health
MUSC Health is the clinical enterprise of the Medical University of South Carolina (MUSC), comprised of a 700-bed medical center, the MUSC College of Medicine and the physician’s practice plan. It serves patients across South Carolina and beyond through four hospital facilities in Charleston and more than 100 outreach sites. Among these are the Hollings Cancer Center, the only National Cancer Institute-designated center in the state, and a nationally recognized Children’s Hospital. The Medical University was founded in 1824 and has become a premiere academic health sciences center at the forefront of the latest advances in medicine, with world-class physicians, scientists and groundbreaking research and technology that is often the first of its kind in the world. Visit muschealth.org for more information.